Navigation Links
Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
Date:4/14/2008

profile with reduced gastrointestinal and hematopoietic

toxicity compared to irinotecan with repeat dosing in dogs"

#5742: "NKTR-102, a novel PEGylated-irinotecan, has a superior acute

safety, tolerability, and pharmacokinetic profile compared to irinotecan

in rats and dogs"

Prior data presentations on the anti-tumor activity and pharmacokinetics of NKTR-102 in mouse xenograft models of colorectal, breast and lung cancer can be found at http://www.nektar.com/wt/page/nktr102media.

About NKTR-102

Nektar is developing NKTR-102, a PEGylated form of irinotecan, which was invented by Nektar using its world-leading small molecule PEGylation technology platform. The product is currently in Phase 2 clinical development. Irinotecan is an important chemotherapeutic agent used for the treatment of solid tumors, including colorectal and lung cancers. By applying Nektar's small molecule PEGylation technology to irinotecan, NKTR-102 may prove to be a more powerful and tolerable anti-tumor agent. Preclinical studies show that treatment with NKTR-102 results in significant suppression of tumor growth in an irinotecan-resistant mouse colorectal tumor model and in similar models of breast and lung cancer. Administration of NKTR-102 in an animal model also results in a markedly improved time-concentration profile for SN38, the active metabolite of irinotecan, as compared to treatment with irinotecan.

Nektar PEGylation Platform

Nektar PEGylation technology can enhance the properties of therapeutic agents by increasing drug circulation time in the bloodstream, decreasing immunogenicity and dosing frequency, increasing bioavailability and improving drug solubility and stability. It can also be used to modify pharmaceutical agents to preferentially target certain systems within the body. It is a technique in which non-toxic polyethylene glycol (PEG) polyme
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
6. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
7. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
8. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
9. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
10. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
11. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Oct. 31, 2014  Lycera Corp., a biopharmaceutical ... autoimmune disease and cancer, today announced that data ... agonist product candidates will be presented at the ... Cancer (SITC) being held November 6-9, 2014 at ... Harbor, MD.  The poster, entitled " Novel synthetic ...
(Date:10/31/2014)... , Oct. 31, 2014 ThynkWare ( www.thynkware.com ... patients initiate text and email messages using their thoughts. ... technology invented by ThynkWare,s founder, Duane Cash , ... smartphone device. This technology allows users to control their ... power of thought. ThynkWare provides the interface ...
(Date:10/31/2014)... LAVAL, QC , Oct. 31, 2014 /CNW Telbec/ ... is poised, with its strategic plan, for accelerated growth ... 2014 was 32.6% and revenues reached $17,862,341. Net income ... $3 million threshold for the first time in the ... this growth, the Company joined the forces of its ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 2Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 3Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 4Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 5
... CHICAGO and NEW YORK, Dec. 6, 2010 With as ... developing Alzheimer,s,(1) the Alzheimer,s Association and Pfizer (NYSE: ... disease by emphasizing to all Americans, "It,s Time to Face ... related to their personal experience with the disease in an ...
... Following the annual meeting of its stockholders on Friday, ... ) announced that its stockholders approved the reappointment of ... C. Wallen as directors of the Company.  In addition, ... PricewaterhouseCoopers LLP as its independent registered public accounting firm. ...
Cached Medicine Technology:National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's' 2National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's' 3National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's' 4Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm 2Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm 3
(Date:10/31/2014)... to life. The last stage, when two daughter cells ... dawn of cell biology in the Victorian era. For ... study this final step, when the dividing cell creates ... given to this process by those early biologists, cytokinesis, ... a highly active and organized series of events. Scientists ...
(Date:10/31/2014)... — A team from the Broad Institute, the ... California, Santa Cruz, was awarded one of three ... contracts with the goal of building a system ... Genome Atlas (TCGA) and other datasets by co-locating ... one cloud environment. This co-location will enable researchers ...
(Date:10/31/2014)... CA (PRWEB) October 31, 2014 ... also has amazing health effects for practitioners. ... by a Doctor of Science and Movement specializing ... his dedication to pelvic floor reeducation that traditional ... urinary incontinence, Diastasis Recti, Prolepses, etc. , The ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Energy Textiles ... gear. The new gear is now available online, and ... the benefits of Celliant infrared-active athletic gear over compression ... that another contract has been signed for Under Armour ... for the next eight years. In light of this ...
(Date:10/31/2014)... treatment and cost, patients with early stage breast ... (APBI) with proton therapy versus whole breast irradiation ... of Texas MD Anderson Proton Therapy Center. ... on typical patient characteristics, researchers used Medicare reimbursement ... types of partial and whole breast irradiation therapies ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3
... America,s pharmaceutical research companies are testing 109 medicines and ... to a report released today by the Pharmaceutical Research and ... anniversary of "World AIDS Day" - a global awareness campaign ... Health on Programmes for AIDS Prevention. , ...
... allows patients to control their own pain medication, but a new ... Commission Journal on Quality and Patient Safety shows that errors ... in patient harm than errors that occur with other medications. ... than 9,500 PCA errors over a five-year period in the United ...
... for HIV Prevention, Calls on Governments to Increase Investment in ... (Para tener acceso a una copia completa de la declaracion ... , WASHINGTON, Dec. 1 An ... Latina women in the United States is demanding increased access ...
... ARCADIS family of products highlights the cutting-edge of intraoperative imaging ... Siemens Healthcare ( ... family of next-generation ARCADIS(R) C-Arm systems, featuring outstanding image quality, ... 94th Scientific Assembly and Annual Meeting of the Radiological Society ...
... independent study at the,University of Cumbria found that nine in every ... exercising. The games reduce the boredom of,exercise. , ... to use exercise equipment,combined with video games provided by a company ... could play their games only while they maintained movement on,the fitness ...
... Appear in Upcoming TV Commercial - , , ... Whitening Expressions is "FanTaste-ic!" Crest Whitening Expressions and flavor expert ... contest in search of a new catch phrase that best ... "FanTaste-ic" was selected from over 600 contest entries, and America voted ...
Cached Medicine News:Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 2Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 3Health News:Study: Patient Harm More Common with Patient-Controlled Pain Medication 2Health News:Study: Patient Harm More Common with Patient-Controlled Pain Medication 3Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 2Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 3Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Video: America Votes Crest Whitening Expressions Is FanTaste-ic! 2
... Immunoassay (EIA) IgG & IgM Test System is ... presumptive detection of human IgG & IgM antibodies ... system should be used to test serum from ... with B. burgdorferi. All positive and equivocal specimens ...
... TheraTears in a bottle becomes preservative-free ... turns into oxygen and water on ... eyes with mild to moderate dryness ... maintenance treatment. Now you can have ...
... sutures are prepared by coating the ... caprolactone/glycolide copolymer and calcium stearoyl lactylate. ... increase visibility and are also available ... established by the United States Pharmacopeia ...
... QualiCode™ B. burgdorferi IgG/IgM Western Blot Kits ... detection of antibodies to Borrelia burgdorferi. Proteins ... disruption. Purified B. burgdorferi antigens are fractionated ... a polyacrylamide slab gel in the presence ...
Medicine Products: